Inventor
MILES STUART CONGREVE
Inventor
GB
Overview
Patents· 23 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
C07DHeterocyclic compounds30%
A61KPreparations for medical, dental or toiletry purposes28%
C07BGeneral methods of organic chemistry4%
C07CAcyclic or carbocyclic compounds3%
C07KPeptides3%
PatentTitleYear
12,552,799Triazolone compounds202612,528,8155-amino-8-(4-pyridyl)-[1,2,4]triazolo[4,3-c]pyrimidin-3-one compounds for use against cancer202612,492,174Morpholine-3-carboxamide derivatives as prostaglandin E2 receptor 4 (EP4) agonists for the treatment of gastrointestinal and pulmonary diseases202512,441,777GLP-1 receptor antagonists202512,415,7954-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators202512,391,641Prostaglandin EP202512,344,621CGRP antagonist compounds202512,331,029Orexin 1 receptor antagonists202512,240,825Oxexin 1 receptor antagonists202512,234,227Pyrazole derivatives as H4 antagonist compounds202512,227,521CGRP antagonist compounds202512,215,099Quinolinone and benzoxazine derivatives as muscarinic M202512,202,843Muscarinic receptor agonists202512,178,813CGRP receptor antagonists202412,054,4721,2,4-triazine-4-amine derivatives202411,999,745Pharmaceutical compounds202411,987,648Cyclohexapeptides as selective somatostatin SST5 receptor agonists202411,834,407Substituted cyclohexanes as muscarinic M1 receptor and/or M4 receptor agonists202311,793,817Muscarinic M1 receptor agonists202311,680,053Methods of treatment using 4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators202311,584,732Methods of treatment using 4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators202311,352,342Pharmaceutical compounds202211,324,738Muscarinic agonists2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to HEPTARES THERAPEUTICS LTD (9)· patent assignee history
2022–2026Based in GB· patent location history
2024–2026Patents assigned to NXERA PHARMA UK LTD (15)· patent assignee history
2024Patents assigned to ALLERGAN PHARMACEUTICALS THERAPEUTICS INTERNATIONAL LTD (1)· patent assignee history
2025Patents assigned to Nxera Pharma UK Limitied (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NXERA PHARMA UK LTD | 15 | 2024–2026 |
| HEPTARES THERAPEUTICS LTD | 9 | 2022–2025 |
| ALLERGAN PHARMACEUTICALS THERAPEUTICS INTERNATIONAL LTD | 1 | 2024 |
| Nxera Pharma UK Limitied | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| GB | 23 | 2022–2026 |